Humana Says Acthar's Meteoric Price Hike Cost It $700M
Mallinckrodt ran "one of the most outrageous price-gouging schemes in the history of American medicine" on its hormone gel used primarily to treat an infant seizure syndrome, according to a new...To view the full article, register now.
Already a subscriber? Click here to view full article